Clinical trial Recruiting at 1 site Observational Ages 18 and up

Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients

Official title: Enhanced Recovery Pathway for Chronic Subdural Hematoma

Run by Universitaire Ziekenhuizen KU Leuven · NCT07421453 · Data updated 2026-11-12

This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.

More Chronic Subdural Hematoma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven)
StatusRecruiting
StartedDecember 23, 2024
Main results expectedSeptember 30, 2027
Study endsJuly 31, 2028
Registry record updatedFebruary 19, 2026
Trial IDNCT07421453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a chronic subdural hematoma requiring burr-hole drainage who can provide informed consent (or have a legally acceptable representative) are the intended participants.

Probably not a fit

Patients with significant underlying cerebral lesions (for example tumors or vascular lesions) or with prior treatment of the same-sided chronic subdural hematoma are excluded and thus unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational project implements a standardized enhanced recovery protocol (ERP) for patients undergoing burr-hole drainage of chronic subdural hematoma and compares outcomes to a historical cohort. The ERP includes decision guidelines (surgery versus middle meningeal artery embolization), specific surgical technique modifications, and uniform postoperative care pathways. Primary safety outcome is hematoma recurrence at six months, with additional measures of complication rates and 30-day outcomes. Eligible adults treated at the center without major underlying cerebral lesions are enrolled and outcomes are tracked prospectively.

Why it matters

Potential benefit: If successful, the protocol could lower recurrence and complication rates and streamline recovery after burr-hole drainage for chronic subdural hematoma.

How similar studies have gone: Enhanced recovery protocols have improved outcomes in other surgical fields and smaller series suggest benefits for cSDH, but combining decision algorithms, surgical modifications, and embolization pathways in a single ERP is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Existence of a chronic subdural hematoma requiring burr-hole drainage
* Written informed consent to participate in the study must be obtained from the subject. If the subject is not capable of self-consent, all efforts will be made to locate a legally acceptable representative to act on behalf of the subject. When the patient is considered capable to consent but physically unable to sign an informed consent form and a representative is not available an impartial witness can attend the informed consent process.

Exclusion Criteria:

* Existence of an important underlying cerebral lesion (e.g. a vascular lesion, tumor)
* History of treatment (surgical or by middle meningeal artery embolization) of a same sided cSDH

Where it's running

  • University Hospitals Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.